(ONC) BeiGene - Performance 79.2% in 12m
Compare ONC with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
16.76%
#28 in Group
Rel. Strength
94.45%
#445 in Universe
Total Return 12m
79.24%
#17 in Group
Total Return 5y
50.99%
#28 in Group
P/E -
(?) Percentile in Group
P/E Forward 370
92th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -2.65%
68th Percentile in Group
12m Total Return: ONC (79.2%) vs XBI (-6.5%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
-8.25% | 25.2% | 163% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
0.89% | 22.3% | 40.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
| AMGN NASDAQ Amgen |
-11.6% | 4.69% | 33.7% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
| LONN SW Lonza |
-1.09% | 7.58% | 35.2% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
| BIM PA Biomerieux |
-2.83% | 12.9% | -1.51% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
| KMDA NASDAQ Kamada |
-7.32% | 33% | -9.75% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
| ERF PA Eurofins Scientific SE |
9.29% | -9.24% | 24.2% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
| GRFS NASDAQ Grifols |
-7.23% | 11% | -64% | 26.9 | 11 | 0.23 | -45.4% | -33.9% |
Performance Comparison: ONC vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ONC
| Total Return (including Dividends) | ONC | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -1.61% | -10.94% | -6.73% |
| 3 Months | 12.10% | -14.92% | -11.93% |
| 12 Months | 79.24% | -6.46% | 7.24% |
| 5 Years | 50.99% | -19.21% | 100.61% |
| Trend Score (consistency of price movement) | ONC | XBI | S&P 500 |
| 1 Month | -48.4% | -52.8% | -63.5% |
| 3 Months | 31.6% | -92.8% | -90.3% |
| 12 Months | 82.3% | -32.4% | 60.6% |
| 5 Years | -42.3% | -53.3% | 84.2% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #59 | 10.5% | 5.50% |
| 3 Month | #19 | 31.8% | 27.3% |
| 12 Month | #17 | 91.6% | 67.2% |
| 5 Years | #29 | 86.9% | -24.7% |
FAQs
Does ONC BeiGene outperforms the market?
Yes,
over the last 12 months ONC made 79.24%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.46%.
Over the last 3 months ONC made 12.10%, while XBI made -14.92%.
Over the last 3 months ONC made 12.10%, while XBI made -14.92%.
Performance Comparison ONC vs Indeces and Sectors
ONC vs. Indices ONC is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 7.34% | 5.12% | 19.5% | 72.0% |
| US NASDAQ 100 | QQQ | 6.86% | 5.75% | 19.4% | 71.7% |
| US Dow Jones Industrial 30 | DIA | 9.37% | 5.30% | 18.9% | 74.8% |
| German DAX 40 | DAX | 6.12% | 2.33% | -0.41% | 58.9% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 7.91% | 1.78% | 18.3% | 70.0% |
| Hongkong Hang Seng | HSI | 4.67% | 2.11% | 15.0% | 62.5% |
| India NIFTY 50 | INDA | 5.19% | -3.64% | 16.1% | 76.3% |
| Brasil Bovespa | EWZ | 3.07% | -2.07% | 14.4% | 88.0% |
ONC vs. Sectors ONC is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 6.63% | 5.24% | 10.4% | 64.2% |
| Consumer Discretionary | XLY | 5.90% | 5.23% | 14.2% | 68.0% |
| Consumer Staples | XLP | 7.19% | -4.59% | 11.5% | 67.9% |
| Energy | XLE | 7.27% | 10.9% | 20.8% | 91.9% |
| Financial | XLF | 6.64% | 3.24% | 10.6% | 61.4% |
| Health Care | XLV | 9.61% | 6.15% | 21.7% | 81.6% |
| Industrial | XLI | 7.94% | 4.42% | 19.7% | 75.2% |
| Materials | XLB | 7.60% | 4.24% | 26.8% | 85.2% |
| Real Estate | XLRE | 7.57% | 1.62% | 19.8% | 64.5% |
| Technology | XLK | 7.07% | 7.39% | 25.7% | 78.1% |
| Utilities | XLU | 7.45% | -1.81% | 15.9% | 57.6% |
| Aerospace & Defense | XAR | 8.79% | 1.57% | 10.1% | 57.4% |
| Biotech | XBI | 3.92% | 9.33% | 30.9% | 85.7% |
| Homebuilder | XHB | 5.81% | 6.51% | 34.3% | 89.8% |
| Retail | XRT | 5.47% | 3.78% | 22.9% | 85.5% |